1
TÍTULO: Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R (2)) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance
AUTORES: Morschhauser, Franck; Nastoupil, Loretta; Feugier, Pierre; De Colella, Jean Marc Schiano; Tilly, Herve; Palomba, M. Lia; Bachy, Emmanuel; Fruchart, Christophe; Libby, Edward; Casasnovas, Rene Olivier; Flinn, Ian W.; Haioun, Corinne; Maisonneuve, Herve; Ysebaert, Loic; Bartlett, Nancy L.; Bouabdallah, Kamal; Brice, Pauline; Ribrag, Vincent; Le Gouill, Steven; Daguindau, Nicolas; Delwail, Vincent; Pica, Gian Matteo; Martin Garcia Sancho, Alejandro; Lopez Guillermo, Armando; Larouche, Jean Francois; Ando, Kiyoshi; Maria, Gomes da Silva; Andre, Marc; Wu, Ka Lung; Sehn, Laurie H.; Izutsu, Koji; Cartron, Guillaume; Gkasiamis, Argyrios; Crowe, Russell; Xerri, Luc; Fowler, Nathan H.; Salles, Gilles; ...Mais
PUBLICAÇÃO: 2021, FONTE: BLOOD, VOLUME: 138
INDEXADO EM: WOS
2
TÍTULO: Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study. Statin use in follicular lymphoma  Full Text
AUTORES: Emmanuel Bachy; Jane A Estell; Eric Van de Neste; Reda Bouabdallah; Joan Bargay; Alain Delmer; Benedicte Gelas Dore; Maria Gomes da Silva; Olivier Fitoussi; David Belada; Herve Maisonneuve; Tanin Intragumtornchai; Thierry Lamy; Peggy Dartigues; John Francis Seymour; Gilles Salles;
PUBLICAÇÃO: 2016, FONTE: AMERICAN JOURNAL OF HEMATOLOGY, VOLUME: 91, NÚMERO: 4
INDEXADO EM: Scopus WOS CrossRef